Clinical Trials Browser

Phase 2 × dinaciclib × Plasma cell × Clear all

NCT01096342 2014-06-18

Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

16 enrolled 6 charts

Multiple Myeloma